home · filing · 0001104659-21-107566
8-K
filed August 19, 2021, 7:59 PM ET
ticker XXII
CIK 0001347858
leadership
confidence high
sentiment neutral
materiality 0.40
22nd Century Group appoints Anthony Johnson to Board of Directors
22nd Century Group, Inc.
Anthony Johnson appointed as Class II director effective August 18, 2021.
Johnson is co-founder, President, CEO of Kodikaz Therapeutic Solutions and founding partner of Buffalo Biosciences.
Will serve on Scientific, Finance and Compensation Committees; receives standard non-employee director compensation.
Bring experience in biotechnology, genomics, and life sciences; held roles at Empire Genomics and Thermo Fisher.
Executive movements
Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements .
Effective 2021-08-18
Filed August 19, 2021, 7:59 PM ET
appointed Anthony Johnson, to be a director on the Board, effective immediately.
Key facts
Extracted from this filing and checked against the source text.
Executive change
SEC 8-K Item 5.02
confidence 1.0
Anthony Johnson was appointed as Director at 22nd Century Group, Inc..
Action appointed
Role Director
Exact text from the filing
appointed Anthony Johnson, to be a director on the Board, effective immediately.
View on SEC.gov
Source: SEC EDGAR
accession 0001104659-21-107566
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.